Healthstream HSTM
- Market cap
- $1B
- PE
- 48.8×
- 10y median 54.3×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 3.2×
- EV/EBIT
- 37.8×
- Revenue, 12 months
- $321.1M
- +9% on a year ago
- Net margin
- 6.6%
- Free cash flow yield
- 6.8%
Healthstream trades at 48.8× trailing earnings, near its ten-year median. Revenue was $321.1M over the last twelve months, up 9% on a year earlier with a 7% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $70.3M+5% | $70.6M+3% | $72.8M+6% | $71.6M+3% | $73.1M+4% | $74.2M+5% | $73.5M+1% | $74.4M+4% | $76.5M+5% | $79.7M+7% | $81.2M+11% | $83.7M+13% | |
| Cost of revenue | $23.6M+1% | $24M+2% | $24.6M+3% | $23.7M+1% | $24.5M+4% | $25.1M+5% | $25.5M+4% | $26.4M+11% | $26.5M+8% | $28.9M+15% | $27.8M+9% | $29M+10% |
| Gross profit | $46.8M+7% | $46.6M+4% | $48.1M+7% | $47.8M+5% | $48.6M+4% | $49.1M+6% | $48M−0% | $48M+0% | $50M+3% | $50.9M+4% | $53.4M+11% | $54.7M+14% |
| R&D | $10.9M−5% | $11.9M+1% | $12M+3% | $12.1M+10% | $12.1M+11% | $12.7M+6% | $12M+0% | $12.1M+0% | $12.1M+0% | $14.8M+16% | $13.6M+13% | $13.6M+13% |
| SG&A | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| $4.9M+104% | $4.3M+38% | $5.7M+97% | $4.4M+10% | $6.5M+34% | $4.7M+10% | $4.4M−23% | $5.9M+33% | $7.6M+17% | $2.4M−49% | $7.5M+72% | $8.3M+41% | |
| Pre-tax income | $5.5M+11% | $5.4M+66% | $6.5M+108% | $5.3M+18% | $7.5M+37% | $5.5M+1% | $5.2M−20% | $6.9M+30% | $8.3M+10% | $2.9M−48% | $7.8M+49% | $8.7M+27% |
| $1.6M+26% | $827K+1% | $1.3M+154% | $1.1M+208% | $1.8M+11% | $594K−28% | $916K−30% | $1.5M+31% | $2.2M+24% | $317K−47% | $1.9M+109% | $2M+37% | |
| Net income | $3.9M+6% | $4.6M+87% | $5.2M+99% | $4.2M+1% | $5.7M+48% | $4.9M+7% | $4.3M−17% | $5.4M+29% | $6.1M+6% | $2.5M−48% | $5.9M+36% | $6.7M+24% |
| $0.13+8% | $0.15+88% | $0.17+89% | $0.14+8% | $0.19+46% | $0.16+7% | $0.14−18% | $0.18+29% | $0.20+5% | $0.09−44% | $0.20+43% | $0.23+28% | |
| 30.8M+0% | 30.5M−1% | 30.4M−1% | 30.5M−1% | 30.6M−1% | 30.6M+1% | 30.6M+1% | 30.4M−0% | 29.8M−3% | 29.7M−3% | 29.4M−4% | 29.3M−4% |
Gross profit: 65 periods, Q2 FY10 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 16 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 14 periods, Q4 FY10 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY16 and Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Application nearest Healthstream's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| HSTMHealthstream | $1B | 48.8× | 54.3× | 3.2× | +9% | 6.6% | |
| UPWKUpwork | $1.2B | 12.5× | 15.9× | 1.5× | +2% | 12.9% | |
| LZLegalzoom.Com | $1.2B | 77.7× | 68.5× | 1.5× | +12% | 2.1% | |
| GDRXGoodRx | $1.2B | 88.5× | 55.6× | 1.5× | −2% | 2.1% | |
| EVEREverQuote | $801.4M | 7.4× | 18.5× | 1.1× | +23% | 15.2% | |
| TASKTaskUs | $784.8M | 7.4× | 26.3× | 0.6× | +11% | 8.8% | |
| YEXTYext | $727.5M | 38.7× | 48.3× | 1.6× | −1% | 5.9% | |
| MNTNMNTN | $724.1M | 12.9× | 15.1× | 2.3× | +21% | 18.0% | |
| NRDSNerdwallet | $698.7M | 12.3× | 15.9× | 0.8× | +12% | 7.6% | |
| IBEXIBEX | $627.1M | 15.1× | 11.5× | 1.0× | +15% | 7.2% | |
| CARSCars.com | $585.6M | 19.2× | 27.3× | 0.8× | +1% | 4.7% | |
| Peer median | $756.2M | 14.0× | 22.4× | 1.3× | +11% | 7.4% |
More on Healthstream
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Software - Application
- Sector
- Technology
Valuation data, not investment advice. Prices as of .